Escherichia coli-tubular cell interaction modulates renal medullary interstitial cell proliferation and collagen accumulation

Cellular Physiology and Biochemistry

Volumn 6, Issue 4, 1996, Pages 223-233

  Sankaran, Ramkumar T ^a,b   Mattana, Joseph ^a,b   Shanna, Pratima ^a,b   Sharma, Saroj ^a,b   Singhal, Pravin C ^a,b  

^a LONG ISLAND JEWISH MEDICAL CENTER   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Escherichia coli tubular cell interaction; Interstitial scarring; Proximal tubular cells

Indexed keywords

COLLAGEN; INTERLEUKIN 6 ANTIBODY; MESSENGER RNA;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ESCHERICHIA COLI; KIDNEY CELL; KIDNEY FIBROSIS; NONHUMAN; OPOSSUM; PRIORITY JOURNAL; RAT;

ANIMALIA; BACTERIA (MICROORGANISMS); DIDELPHIDAE; ESCHERICHIA COLI;

EID: 0029972286     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000154825     Document Type: Article

References (35)

1. Risdon RA. Sloper JC. De Warden-cr HE: Relationship between renal function and histological changes found in renal biopsy specimens from patients with persistent glomerulonephritis. Lancet 1968;i: 363-366.
2. Schainuck LI, Striker GR. Cutler RE, Benditt EP: Structure-functional correlations in renal disease. II. The correlations. Hum Pathol 1970: 1:631-640.
3. Striker GE, Schainuck LI. Cutler RE, Benditt EP: Structural-functional correlations in renal disease. I. A method for assaying and classifying histopathologic changes in renal disease. Hum Pathol 1970:1: 615-630.
4. Bohle A. Mackcnsin-Haen S, Gisc H. Grund KE, Wehrmann M, Batz Ch, Bogenschütz O, Schmitt H. Nagy J, Muller C, Müller G: The consequences of tubulo-interstitial changes for renal function in glomerulopathies. Pathol Res Pracl 1990; 186:135-144.
5. Hooke DH, Gee DC, Atkins RC: Leukocyte analysis using monoclonal antibodies in human glomerulonephritis. Kidney Int 1987,31:964-972.
6. Fraser IR. Birch D, Fairly KF, John S, Lichtenstein M, Tress B. Kincaid-Smith PS: A prospective study of cortical scarring in acute febrile pyelonephritis in adults: Clinical and bacteriological characteristics. Clin Nephrol 1995;43:159-164.
7. Huland H, Bausch R: Chronic pyelonephritis as a cause of end-stage renal disease. J Urol 1982; 127:642- 643.
8. Straube E. Schmidt G, Marre R, Hacker J: Adhesion and internalization of E. coli strains expressing various pathogenicity determinants. Int J Med Microbiol Virol Parasitol Infect Dis 1993:278:218-228.
9. Shimamura T. Maesaka JK: Phagocytosis of E. coli by renal tubular epithelia. Yale J Biol Med 1984:57: 817-824.
10. Burrell JH, Yong JL, Macdonald GJ: Experimental analgesic nephropathy: Changes in renal structure and urinary concentrating ability in Fisher 344 rats given continuous low doses of aspirin and paracetamol. Pathology 1990;22:33-44.
11. Jackson NM. Hsu CH, Visschcr GE. Venkatachalam MA, Humes HD: Alterations in renal structure and function in a rat model of cyclosporine nephrotoxicity. J Pharmacol Exp Ther 1987;242:749-756.
12. Johnson JR, Roberts PL. Stamm WE: P fimbriae and other virulence factors in Escherichia coli urosepsis: Association with patients’ characteristics. J Infect Dis 1987:156:225-229.
13. Oilman L, Hed J, Stendahl O: Interaction between human polymorphonuclear leukocytes and two different strains of type 1 fimbriae-bearing Escherichia coli. J Infect Dis 1982; 146:751-757.
14. Hedges S. Svensson M, Svanborg C: Interleukin-6 response of epithelial cell lines to bacterial stimulation in vitro. Infect Immun 1992:60:1295- 1301.
15. Koyama H, Goodpasture C, Miller MM, Teplitz RL, Riggs AD Establishment and characterization of a cell line from the American opossum (Didelphis virginiana). In Vitro 1978;14:239-246.
16. Mattana J, Gibbons N, Singhal PC: Cocaine interacts with macrophages to modulate mesangial cell proliferation. J Pharmacol Exp Ther 1994: 271:311-318.
17. Navarro S. Deblili N. Le Couedic J, Klein B. Breton-Gorius J, Doly J, Vainchenker W: interleukin-6 and its receptor are expressed by human megakaryocytes: In vitro effects on proliferation and endoreplication. Blood 1991;77:461-471.
18. Fukatsu T, Matsuo S, Yukio Y, Miyai H, Futenma A. Kato K: Expression of interleukin 6 and major histocompatibility complex molecules in tubular epithelial cells of diseased human kidneys. Lab Invest 1993:69:58-67.
19. Singhal PC, Gibbons N, Abramovici M: Long-term effects of morphine on mesangial cell proliferation and matrix synthesis. Kidney Int 1992; 41:1566-1570.
20. Yamaguchi Y, Mann DM, Ruoslah-ti E: Negative regulation of transforming growth factor- by the pro-teoglvcan decorin. Nature 1990:346: 281-284.
21. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-159.
22. Freedman LR: Natural history of urinary tract infection in adults. Kidney Int 1975;4(suppl):96- 100.
23. Donckerwolke RA, Brover M, Brunner FP, Brynger H, Jacobs C, Kramer P, Selwood NH, Wing AJ: Combined report on regular dialysis and transplantation in Europe. XL 1981. Proc Eur Dial Transplant Assoc 1983:19:61-91.
24. Murray T. Goldberg M: Chronic interstitial nephritis: Etiologic factors. Ann Intern Med 1975;82:453-459.
25. Mayrier A, Condamin MC, Fernet M. Labigne-Roussel A. Simon P, Callard P, Rainfray M. Souillex M, Groc A: Frequency of development of early cortical scarring in acute primary pyelonephritis. Kidney Int 1989;35:696-703.
26. Hedges S, Stcnqvist K. Lidin-Jan-son G, Martincll J, Sandberg T, Svanborg C: Comparison of urine and serum concentrations of intcr-leukin-6 in women with acute pyelonephritis of asymptomatic bacleri-uria. J Infect Dis 1992:166:653- 656.
27. Ohta K, Takano N. Seno A, Yachie A. Miyawaki T. Yokohama H, To-mosugi N. Kato E, Taniguchi N: Detection and clinical usefulness of urinary intcrleukin-6 in the diseases of the kidney and urinary tract. Clin Nephrol 1992:38:185-189.
28. Hedges S, Anderson P, Lidin-Jan-son G, Dc Man P. Svanborg C: ln-tcrleukin-6 response to deliberate colonization of the human urinary tract with gram-negative bacteria. Infect Immun 1991;59:421-427.
29. Hedges S, Svensson M. Svanborg C: lnterleukin-6 response of epithelial cell lines to bacterial stimulation in vitro. Infect Immun 1992:60:1295-1301.
30. Sharma K, Ziyadeh FN: The emerging role of transforming growth fac-tor-p in kidney diseases. Am J Physiol 1994;266:F829-F842.
31. Roberts AB, McCune BK, Sporn MB: TGF-P: Regulation of extracellular matrix. Kidney Int 1992;41: 557-559.
32. Sharma S, Sankaran RT, Shan Z, Gibbons N. Singhal PC: Escherichia co/t-macrophage interactions modulate mesangial cell proliferation and matrix synthesis. Nephron 1996;73: 587-596.
33. Tamaki K, Okuda S. Ando T, Iwa-moto T, Nakayama M, Fujishima M: TGF-pi in glomerulosclerosis and interstitial fibrosis of Adriamy-cin nephropathy. Kidney Int 1994; 45:525-536.
34. Rugo HS. O'Hanley P. Bishop AG, Piarce MK. Abrams JS. Howard M. O’Garra A: Local cytokine production in a murine model of Escherichia coli pyelonephritis. J Clin Invest 1992;89:1032-1039.
35. Kaneto H. Morrissey J. Klahr S: Increased expression of TGF-p 1 mRNA in the obstructed kidney of rats with unilateral ureteral ligation. Kidney Int 1993;44:313-321.